JNJ Johnson and Johnson

NEW BRUNSWICK, N.J., Aug. 26, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Cantor Virtual Global Healthcare Conference on Tuesday, September 28^th.  Mathai Mammen, Global Head, Research & Development Janssen Research Development and Scott White, Company Group Chairman NA Pharmaceuticals will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-cantor-virtual-global-healthcare-conference-301363618.html

SOURCE Johnson & Johnson